 Connection
Janetta Iwanicki to Delayed-Action Preparations
This is a "connection" page, showing publications Janetta Iwanicki has written about Delayed-Action Preparations.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.699 |
|
|
|
-
Iwanicki JL, Severtson SG, McDaniel H, Rosenblum A, Fong C, Cicero TJ, Ellis MS, Kurtz SP, Buttram ME, Dart RC. Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States. PLoS One. 2016; 11(12):e0167499.
Score: 0.519
-
Severtson SG, Haanschoten EE, Iwanicki J, Dart RC. Differences in severity of poison centers exposures involving XTAMPZA? ER versus other opioid analgesics. Pain Manag. 2023 Sep; 13(9):519-527.
Score: 0.052
-
Jewell J, Black J, Ellis M, Olsen H, Iwanicki J, Dart R. A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population. Clin Drug Investig. 2023 Mar; 43(3):197-203.
Score: 0.050
-
Geoffrey Severtson S, Kreider SED, Amioka EC, Margolin ZR, Iwanicki JL, Dart RC. Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER. Pain Med. 2020 12 25; 21(12):3660-3668.
Score: 0.043
-
Dart RC, Iwanicki JL, Dasgupta N, Cicero TJ, Schnoll SH. Do abuse deterrent opioid formulations work? J Opioid Manag. 2017 Nov/Dec; 13(6):365-378.
Score: 0.035
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|